Wordt geladen...
2389. Effect of Rezafungin on QT Interval in Healthy Subjects
BACKGROUND: Rezafungin (RZF), a novel, once-weekly echinocandin for treatment and prophylaxis of invasive fungal infections, successfully met safety and efficacy endpoints in Phase 2 and is advancing to Phase 3 studies. RZF is the first echinocandin to undergo a definitive QT evaluation. METHODS: Th...
Bewaard in:
| Gepubliceerd in: | Open Forum Infect Dis |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6255498/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.2042 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|